Takeda Enters Into Two-Year Contract with Canadian Blood Services for GLASSIA®, Treatment for Rare form of Emphysema
Availability of GLASSIA® represents significant milestone for patients with emphysema due to severe hereditary deficiency of Alpha-1 antitrypsin For Canadian Audiences Only TORONTO, ON – Takeda Canada Inc. (Takeda) has entered… Read More




